2015 ACBS Landline-Cellphone Combined Prevalence Tables
BRFSS Asthma Call-back Survey Prevalence TABLE 2
| State/Territory | Sample size± |
Active | Inactive | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Sample size |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | ||
| Connecticut | 511 | 385 | 72.8 | 3.1 | (66.7 – 78.9) | 126 | 27.2 | 3.1 | (21.1 – 33.3) |
| Florida | 326 | 238 | 67.7 | 4.2 | (59.5 – 75.9) | 88 | 32.3 | 4.2 | (24.1 – 40.5) |
| Georgia | 247 | 179 | 65.5 | 4.6 | (56.5 – 74.5) | 68 | 34.5 | 4.6 | (25.5 – 43.5) |
| Hawaii | 257 | 192 | 73.0 | 4.4 | (64.4 – 81.6) | 65 | 27.0 | 4.4 | (18.4 – 35.6) |
| Indiana | 300 | 223 | 68.3 | 4.6 | (59.3 – 77.3) | 77 | 31.7 | 4.6 | (22.7 – 40.7) |
| Iowa | 261 | 195 | 70.6 | 4.0 | (62.8 – 78.4) | 66 | 29.4 | 4.0 | (21.6 – 37.2) |
| Kansas | 830 | 620 | 70.5 | 2.2 | (66.2 – 74.8) | 210 | 29.5 | 2.2 | (25.2 – 33.8) |
| Maine | 367 | 275 | 71.2 | 3.7 | (63.9 – 78.5) | 92 | 28.8 | 3.7 | (21.5 – 36.1) |
| Massachusetts | 352 | 280 | 76.4 | 3.3 | (69.9 – 82.9) | 72 | 23.6 | 3.3 | (17.1 – 30.1) |
| Michigan | 538 | 443 | 78.1 | 2.5 | (73.2 – 83.0) | 95 | 21.9 | 2.5 | (17.0 – 26.8) |
| Minnesota | 827 | 634 | 74.4 | 1.9 | (70.7 – 78.1) | 193 | 25.6 | 1.9 | (21.9 – 29.3) |
| Mississippi | 215 | 174 | 72.9 | 5.7 | (61.7 – 84.1) | 41 | 27.1 | 5.7 | (15.9 – 38.3) |
| Missouri | 256 | 206 | 70.1 | 5.8 | (58.7 – 81.5) | 50 | 29.9 | 5.8 | (18.5 – 41.3) |
| Montana | 197 | 149 | 77.5 | 4.4 | (68.9 – 86.1) | 48 | 22.5 | 4.4 | (13.9 – 31.1) |
| Nebraska | 683 | 509 | 66.8 | 3.5 | (59.9 – 73.7) | 174 | 33.2 | 3.5 | (26.3 – 40.1) |
| Nevada | 145 | 114 | 74.4 | 6.5 | (61.7 – 87.1) | 31 | 25.6 | 6.5 | (12.9 – 38.3) |
| New Hampshire | 280 | 218 | 74.0 | 4.4 | (65.4 – 82.6) | 62 | 26.0 | 4.4 | (17.4 – 34.6) |
| New Jersey | 598 | 449 | 70.9 | 3.1 | (64.8 – 77.0) | 149 | 29.1 | 3.1 | (23.0 – 35.2) |
| New Mexico | 354 | 278 | 73.1 | 4.3 | (64.7 – 81.5) | 76 | 26.9 | 4.3 | (18.5 – 35.3) |
| New York | 311 | 241 | 76.6 | 3.5 | (69.7 – 83.5) | 70 | 23.4 | 3.5 | (16.5 – 30.3) |
| Ohio | 522 | 432 | 79.5 | 3.3 | (73.0 – 86.0) | 90 | 20.5 | 3.3 | (14.0 – 27.0) |
| Oregon | 283 | 223 | 77.7 | 3.5 | (70.8 – 84.6) | 60 | 22.3 | 3.5 | (15.4 – 29.2) |
| Pennsylvania | 285 | 226 | 70.3 | 5.8 | (58.9 – 81.7) | 59 | 29.7 | 5.8 | (18.3 – 41.1) |
| Rhode Island | 266 | 221 | 76.8 | 5.2 | (66.6 – 87.0) | 45 | 23.2 | 5.2 | (13.0 – 33.4) |
| Texas | 554 | 426 | 75.5 | 3.7 | (68.2 – 82.8) | 128 | 24.5 | 3.7 | (17.2 – 31.8) |
| Utah | 532 | 405 | 77.0 | 2.4 | (72.3 – 81.7) | 127 | 23.0 | 2.4 | (18.3 – 27.7) |
| Vermont | 352 | 256 | 69.5 | 3.5 | (62.6 – 76.4) | 96 | 30.5 | 3.5 | (23.6 – 37.4) |
| Wisconsin | 347 | 291 | 82.3 | 2.9 | (76.6 – 88.0) | 56 | 17.7 | 2.9 | (12.0 – 23.4) |
| Puerto Rico | 429 | 330 | 66.0 | 3.7 | (58.7 – 73.3) | 99 | 34.0 | 3.7 | (26.7 – 41.3) |
| 29 states / area | 11,425 | 8,812 | 73.4 | 1.0 | (71.4 – 75.4) | 2,613 | 26.6 | 1.0 | (24.6 – 28.6) |
| Median | 73.0 | 27.0 | |||||||
| Range | 65.5-82.3 | 17.7-34.5 | |||||||
1 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
2 Reported none of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
3 Aged ≥ 18 years
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
Page last reviewed: June 11, 2018